Dawson James Securities, Inc.
1 North Federal Highway, 5th Floor
Boca Raton, FL 33432
January 24, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:Biocept, Inc.
Registration Statement on Form S-1
File No. 333-221648
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as placement agent for the proposed offering, hereby joins the request of Biocept, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m. (Washington, D.C. time) on Thursday, January 25, 2018, or as soon as practicable thereafter.
In connection with this acceleration request and pursuant to Rule 460 under the Securities Act, please be advised that between January 24, 2018 and the time of this letter, approximately 1,400 copies of the preliminary prospectus dated January 24, 2018 were distributed to placement agents, dealers, institutions and others.
The undersigned advise that the placement agents have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson James Securities, Inc.
By: /s/ Robert D. Keyser, Jr.
Name:Robert D. Keyser, Jr.
Title:CEO
1